Physician profile
David Botros
NPI 1497360556
$7,671.76
in general payments reported to CMS, 2019-2025
12 companies · $1,709 in 2025
The $1,709 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,330 · 2024: $3,633 · 2025: $1,709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,746 · Travel and Lodging: $2,926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,745.53 |
| Travel and Lodging | $2,926.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,424.79 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $2,269.29 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept Rf Probe, Superion Indirect Decompression System |
| Abbott Laboratories | $1,728.55 | 2023-2025 | Proclaim, Eterna |
| Si-Bone, INC. | $853.38 | 2024 | |
| Integra Lifesciences Corporation | $103.85 | 2023 | Cusa Clarity, Codman Hakim, Codman Certas |
| Spr Therapeutics, INC | $96.91 | 2024 | Sprint Pns System |
| Spinal Simplicity, LLC | $96.08 | 2025 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $28.31 | 2023 | Mild Device Kit |
| Stryker Corporation | $24.92 | 2024 | Mild Device Kit |
| Abbvie INC. | $17.67 | 2025 | |
| Collegium Pharmaceutical, INC. | $14.44 | 2025 | Belbuca |
| Pfizer INC. | $13.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Botros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.